Immunitybio Inc (IBRX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 14,25 US Dollar | 3 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 1.059.836.273 | 30,67 | 7,96 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Immunitybio Inc
Mitarbeiter 684
Handelsplatz NASDAQ
Ticker Symbol IBRX
IPO Datum 2015-07-28
Adresse 3530 John Hopkins Court, San Diego, CA, United States, 92121
Webseite https://immunitybio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc. | Founder, Executive Chairman and Global Chief Scientific & Medical Officer |
| 2 | Mr. Richard Gerald Adcock | President, CEO & Director |
| 3 | Mr. David C. Sachs | Chief Financial Officer |
| 4 | Ms. Regan J. Lauer | Chief Accounting Officer |
| 5 | Dr. Barry J. Simon M.D. | Chief Corporate Affairs Officer & Director |
| 6 | Dr. Enrique Diloné Ph.D., RAC | Chief Technology Officer |
| 7 | Ms. Sarah Singleton | Chief Communications Officer & Head of Patient Advocacy |
| 8 | Ms. Emily Arison | Senior Vice President of Human Resources |
| 9 | Dr. Leonard S. Sender M.D. | Chief Medical Officer of Liquid Tumors & Cell Therapy |
| 10 | Dr. Sandeep K. Reddy M.D. | Chief Medical Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 3,22% | 0,30 Mrd. USD |
| 2 | State Street Corp | 2,02% | 0,19 Mrd. USD |
| 3 | Vanguard Portfolio Management, LLC | 1,69% | 0,16 Mrd. USD |
| 4 | Vanguard Capital Management, LLC | 1,48% | 0,14 Mrd. USD |
| 5 | D. E. Shaw & Co LP | 1,09% | 0,10 Mrd. USD |
| 6 | Two Sigma Investments LLC | 1,05% | 0,10 Mrd. USD |
| 7 | Geode Capital Management, LLC | 0,93% | 0,09 Mrd. USD |
| 8 | Millennium Management LLC | 0,53% | 0,05 Mrd. USD |
| 9 | Northern Trust Corp | 0,34% | 0,03 Mrd. USD |
| 10 | Morgan Stanley - Brokerage Accounts | 0,32% | 0,03 Mrd. USD |
| 11 | The Goldman Sachs Group Inc | 0,31% | 0,03 Mrd. USD |
| 12 | UBS Group AG | 0,30% | 0,03 Mrd. USD |
| 13 | Charles Schwab Investment Management Inc | 0,27% | 0,03 Mrd. USD |
| 14 | Woodline Partners LP | 0,24% | 0,02 Mrd. USD |
| 15 | SEB Asset Management AB | 0,23% | 0,02 Mrd. USD |
| 16 | Vanguard Fiduciary Trust Co | 0,23% | 0,02 Mrd. USD |
| 17 | Bank of America Corp | 0,21% | 0,02 Mrd. USD |
| 18 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0,16% | 0,02 Mrd. USD |
| 19 | Federated Hermes Inc | 0,16% | 0,02 Mrd. USD |
| 20 | Royal Bank of Canada | 0,15% | 0,01 Mrd. USD |